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Abstract Gelsolin is built up of six homologous segments that 
perform different functions on actin. Segments 1 and 2, which are 
suggested to be highly similar in their overall folds, bind 
monomeric and fdamentous actin respectively. A long a-helix 
in segment 1 forms the major contact site of this segment with 
actin. We show that sequence 197-226 of segment 2, equivalent 
to the region around the actin binding helix in segment 1, 
contains F-actin binding activity. Consequently, positionally 
similar parts of segment 1 and 2 are implicated in the actin 
contact and solvent exposed residues in these parts must have 
evolved differentially to meet their different actin binding 
properties. 
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1. Introduction 
Gelsolin is a 83 kDa actin binding protein, ubiquitously 
present in vertebrates, both in the cytoplasm and in extracel- 
lular fluids [l]. It is probably the most versatile actin modu- 
lating protein; in vitro it binds actin monomers, promotes 
nucleation, binds filaments, breaks them and shields their 
fast-growing ends. This actin binding activity is regulated by 
Ca2+ and phosphoinositides, pointing at a key role for gelso- 
lin in signal transduction and microfilament rearrangements 
[2]. It belongs to a superfamily of actin binding proteins (ad- 
ditionally containing villin, severin, fragmin and others) and 
has evolved from a small unit of approximately 15 kDa ([3] 
and references therein). Gelsolin consists of six such repeats 
whose functions in actin binding were characterized using 
limited proteolysis and recombinant techniques [4-61. Both 
segment 1 (Sl, residues l-149 in human gelsolin (HGS)) 
and segments 46 (S46, residues 407-755 in HGS) bind actin 
monomers. Pope et al. [7] showed that actin binding by the 
COOH-terminal half of gelsolin is restricted to S4, while S5 
and S6 are involved in Ca*+ regulation. Sl and S4 bind to a 
similar site on the actin molecule [8] and their simultaneous 
binding to two monomers underlies the nucleation promoting 
property of gelsolin. Segments 2-3 (S2-3, residues 150406 
in HGS) form the F-actin binding part and this binding is 
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Ca2+-independent and stoichiometric. Deletion analysis lim- 
ited the filament binding site to S2 [9]. 
Filament severing and capping have been proposed to occur 
in two consecutive steps. First, S2 binds to the side of the 
filament and positions Sl, which in its turn disrupts actin- 
actin contacts. Sl stays strongly bound to the newly made 
barbed end and prevents both dissociation and association 
of actin monomers. Experimental evidence underlies this mod- 
el. Way et al. [lo] demonstrated that a chimera of gelsolin Sl 
and the a-actinin F-actin binding unit forms a functional 
filament severing and capping protein. Yu et al. [l l] showed 
that gCap39, a gelsolin homologue that caps but does not 
sever filaments, gains the severing function when Sl of 
gCap39 was linked to S223 of gelsolin, indicating that the 
F-actin side-binding (by S2) is a prerequisite for efficient sev- 
ering. Consequently, the effect on severing is often used as an 
assay because of the necessity of F-actin binding for this ac- 
tivity. 
Recently, structural data, both of isolated segments and of 
segments in complex with monomeric actin, have emerged 
elucidating actin binding at the molecular level [12-141. Gel- 
solin Sl binds in the cleft between actin subdomains 1 and 3 
and contacts them through a long a-helix (residues 95-l 12 in 
HGS) located near the end of segment 1. NMR analysis re- 
vealed that S2 of severin has a highly similar fold to Sl of 
gelsolin and villin. 
While the actin interacting residues in Sl have been clearly 
defined, the filament binding sequence of S2 is not yet known 
in detail. Several studies, analyzing either COOH-terminal 
extension of Sl [7,15] or NHz-terminal shortening of S2 
[16], suggest that the NHs-terminus of S2 (residues 150-173) 
is involved. A synthetic villin peptide (residues 133-147, cor- 
responding to gelsolin residues 1599171) binds to actin and 
mutation of basic residues in this sequence affects severing 
[17]. However, several observations suggest that still other 
residues of segment 2 are involved in F-actin side-binding. 
The severing activity of recombinant gelsolin (l-160) or sever- 
in (l-177) fragments containing only small portions of S2 (11 
and 26 residues of S2, respectively) is marginal compared to 
the maximal activity. In contrast, severin l-277, containing Sl 
and the entire S2 domain, has full severing activity [15]. The 
capping protein gCap39 gained severing function by replacing 
sequences in the actin binding helix of Sl and in the NH2- 
terminus of S2 with the respective gelsolin sequences, but 
again maximal activity was not attained [18]. 
In this study we demonstrate that the more COOH-terminal 
part of S2 also contributes to F-actin binding. We show that a 
synthetic peptide containing the sequence of human gelsolin 
segment 2, homologous to the actin binding helix of segment 
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1, binds to F-actin and competes with gelsolin segment S2-3. 
This indicates that the filament binding sequence in gelsolin 
S2 is more extensive than previously thought and suggests 
that within a structurally similar framework different actin 
binding sites have evolved. 
2. Materials and methods 
2.1. Proteins and peptides 
We prepared rabbit skeletal muscle actin following the procedure of 
Spudich and Watt [19] and isolated it as Ca-G-actin by chromatogra- 
phy over Sephadex G-200 in G-buffer (5 mM Tris-HCl pH 7.7, 0.1 
mM CaCla, 0.2 mM ATP, 0.2 mM DTT, 0.01% NaNs). Pyrene-la- 
belled actin was prepared as in [20]. We chemically synthesized the 
gelsolin peptides (PS2 and PSI) on a model 431A peptide synthesizer 
(Applied Biosystems Inc., Foster City, CA). They were purified as in 
[21], checked for correct mass by matrix-assisted laser desorption io- 
nization time of flight mass spectroscopy and their concentration was 
determined as in [21]. The PS2 peptide we used carries an NHz-ter- 
minal cysteine residue, while the internal cysteine (residue 202) is 
replaced by serine. In some experiments we labelled this cysteine 
with N-pyrenyliodoacetamide (Molecular Probes) by adding the label 
in a threefold molar excess to the peptide in 100 mM Tris-HCl pH 8.8. 
The reaction was kept at room temperature overnight and quenched 
with DTT. We oreoared human olasma eelsolin and digested it with . . 
a-chymotrypsin following the procedure in [5]. The gel&n fragments 
were further purified and their concentration determined as in [5]. 
NHs-terminal sequence analysis was performed on a 470A Sequenator 
equipped with an on-line 120A phenylthiohydantoin amino acid ana- 
lyzer (Applied Biosystems Inc.). 
2.2. Actin binding assays and competition assays 
2.2.1. Via chemical crosslinking. A G-actin solution was dialysed 
overnight against phosphate buffer (5 mM K-phosphate pH 7.5, 0.2 
mM CaCla, 0.2 mM ATP, 0.2 mM DTT). As binding to F-actin was 
under study, we induced polymerization by adding KC1 and MgCla 
(respectively 100 mM and 1 mM final concentrations) followed by 20 
min incubation at room temperature. We added the peptide in various 
molar ratios to these preformed actin filaments (final concentration 
3 pM) and incubated them for 1 h at room temperature. Then the 
zero-length crosslinker I-ethyl-3(3-dimethylaminopropyl)carbodiimide 
(EDC) (Sigma) and N-hydroxy-sulfosuccinimide (Pierce) were added 
to a final concentration of 4 mM [22]. The reaction was kept at room 
temperature for another 45 min. We analyzed aliquots of the samples 
on SDS-PAGE mini slab gels which were stained with Coomassie. 
Due to the relatively low concentration of the S2-3 fragment, we 
performed all crosslinking experiments at an F-actin concentration of 
3 pM and incubation times were extended to 1 h at room temperature, 
followed by overnight incubation at 4°C. The S2-3 concentrations 
used are indicated in the figure legends. To assay for competitive 
binding of S2-3 and PS2 using chemical crosslinking, we first added 
a constant amount of PS2 30 pM to a series of samples containing 3 
pM F-actin. After incubation to allow complex formation, we added 
increasing concentrations of S2-3 and again incubated the samples, 
At this point, crosslinker was added and the further procedure was as 
described above. To further demonstrate the peptides’ interaction with 
F-actin protomers, we combined chemical crosslinking with sedimen- 
tation. The samples containing actin in the presence or absence of PS2 
in polymerizing buffer, incubated with the crosslinker as outlined 
above, were spun at 100OOO~g in a Beckman airfuge for 20 min at 
room temperature. Supernatants and resuspended pellets were ana- 
lyzed on SDS-mini slab gels followed by Coomassie staining. 
2.2.2. Via Juorometric measurements. We added the peptide in 
increasing concentration (O-180 pM, 10% labelled) to a series of sam- 
ples containing 4 pM F-actin and allowed them to interact overnight 
at room temperature to ensure equilibrium was reached. A series 
containing only peptide was also prepared. The measured fluorescence 
of this series was subtracted from the fluorescence of the samples 
containing F-actin, which resulted in a nett fluorescence. This nett 
relative steady-state fluorescence was plotted against the total concen- 
tration of peptide. We calculated a Kd for the peptide-F-actin inter- 
action using the equation 
l/AP* = K&PtA,(l/l +k)] + l/[At(l/l +k)] 
with At and Pt the total concentrations of F-actin and peptide (label- 
led+non-labelled) respectively. AP’ is the equilibrium concentration 
of the complex of F-actin subunits with labelled peptide and k the 
ratio of non-labelled over labelled peptide. This equation is derived 
from the one for the equilibrium dissociation constant (Kd) of the 
peptide-actin complex, assuming (i) that the affinity of labelled and 
non-labelled peptide for F-actin is the same and (ii) that at the molar 
ratios in the experiment, the amount of free peptide equals the total 
amount of peptide, i.e. the amount of bound peptide is negligible. To 
meet this last requirement, we only used data points in which the 
molar ratio of peptide versus actin was higher than 40. In this assay 
the measured relative fluorescence is directly proportional to AP‘. By 
plotting l/fluorescence versus l/P, we derived the & from the point of 
intersection with the X-axis (at Y=O, X= -l/G). 
We also tested the competitive character of PS2 and S2-3 using a 
severing assay. In this assay actin filaments (12 t.rM, 25% pvrene 
labelled) that are precapped at their barbed end by. gelsolin (<O- nM) 
are diluted to 0.4 uM in G-buffer. The rate of deoolvmerization is 
proportional to the concentration of pointed filamem ends and con- 
sequently increases when additional gelsolin is added and exerts its 
severing activity on F-actin especially when the sample is simulta- 
neously diluted below the critical monomer concentration of the 
pointed end (final gelsolin concentration is 50 nM). We performed 
this assay after incubation of the filaments for 20 min at room tem- 
perature with 100 l,tM PS2 (or buffer for control samples) prior to 
diluting to 0.4 pM F-actin. 
2.3. Circular dichroism (CD) measurements 
We performed CD measurements at pH 7.5 and 2O”C, scanning 
from 184 to 260 nm, on a Jasco 600 spectropolarimeter with a step 
resolution of 0.5 nm and at a peptide concentration of 40 pM. 3,3,3- 
Trifluoroethanol (TFE) was added to a final concentration of 60%. 
The data are the average of nine scans and are expressed as &law 
(mean residue weight ellipticity) as a function of wavelength. 
2.4. Immunoassays 
The rabbit polyclonal anti-actin antibodies against part of subdo- 
main 4 or against the COOH-terminus were produced by the Centre 
d’Economie rurale, Laboratoire d’hormonologie (Marloie, Belgium). 
Chemicallv svnthesized actin DeDtides (residues 228-257 and 354-375) 
coupled to keyhole limpid hkmocyanin, following the procedure of 
Mumby and Gilman [23], were used as antigen. The monoclonal CC- 
sarcomeric actin specific antibody was obtained from Sigma. Western 
blots of F-actin-S2-3 and F-actin-PS2 were performed as described in 
1241. 
3. Results 
3.1. Residues 198-227 of gelsolin segment 2 are implicated in 
F-actin binding 
The major interaction site of gelsolin Sl with actin is 
formed by an a-helix located in the COOH-terminal part of 
this segment [12]. Structural proof exists that segments 1 and 
2 adopt a similar fold [13], which suggests a functional simi- 
larity in their contact with actin. This urged us to analyze the 
properties of the synthetic peptide covering the S2 region 
homologous to the actin binding helix of Sl. The peptide 
spans S2 residues 198-227 (PS2, Fig. 1). 
We first employed the zero-length crosslinker EDC, which 
covalently couples COOH and NH2 groups in close prox- 
imity at the contact sites, to probe binding of the peptide 
to F-actin. Fig. 2a shows that PS2 crosslinks, ergo binds, 
efficiently to actin under polymerization conditions. At an 
F-actin protomer concentration of 3 PM, 30 pM of peptide 
resulted in 50% crosslinked actin-peptide complex. Spin- 
ning this sample at high speed revealed that the peptide 
actually associates with actin protomers in the preformed fila- 
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Fig. 1. Segmental structure of human gelsolin. The positions of the 
peptides PSI and PS2 are shown as well as the position of the actin 
binding a-helix within these sequences (underlined). The a-helical 
portion of the PS2 sequence is based on the sequence alignment 
with severin domain 2 [13]. 
ments, as the crosslinked actinPS2 complex cosedimented 
(Fig. 2b). 
We synthesized PS2 with a cysteine at its extreme NHa- 
terminus enabling it to be labelled with the fluorophore 
N-pyrenyliodoacetamide. Adding this labelled peptide to poly- 
merized actin in F-buffer results in a rise in fluorescence (Fig. 
2c), most likely due to a change in the environment of the 
attached fluorophore upon formation of the peptide-actin 
complex. Using an actin concentration of 4 PM, a concentra- 
tion of ca. 180 uM of peptide proved to be sufficient to obtain 
a nearly plateau value in fluorescence. From this curve we 
determined (see Section 2 and inset Fig. 2c) an equilibrium 
dissociation constant for the F-actin protomer-PS2 complex 
of ca. 125 PM, note that this is on the assumption that la- 
belled and non-labelled peptide bind with the same affinity. 
3.2. The S2 peptide adopts a similar conformation as the SI 
peptide 
Using circular dichroism as a measure for secondary struc- 
ture, we demonstrate that the peptide 198-227 does not adopt 
a stable or unique conformation in aqueous solution at room 
temperature. However, adding 60% TFE renders a CD spec- 
trum typical for an cc-helix with a maximum at 190 nm and a 
double minimum at 208 and 222 nm (Fig. 3). Fluorinated 
alcohols are known to propagate a-helices by stabilizing inter- 
nal H-bridge formation, but do so only when a helix-forming 
propensity is present [25]. A synthetic peptide (Sl residues 88- 
117) containing the Sl actin binding helix shows a similar 
behavior as the S2 peptide, i.e. random coil in aqueous solu- 
tion and a-helical (as it is in its protein environment [12]) in 
60% TFE (Fig. 3). 
3.3. The S2 peptide (PS2) competes with segment 2+3 
(residues 150407) for binding to F-actin 
As was shown in earlier studies, the a-chymotryptically 
obtained fragment consisting of gelsolin segments 2 and 3 
binds to actin filaments. By NHa-terminal sequence analysis 
we confirmed that the S2-3 we used here starts at segment 2 
residue 150. Adding increasing amounts of S223 to F-actin (3 
PM) preincubated with PS2 (total concentration 30 PM) re- 
sults in a decrease of actin-peptide crosslink concomitant with 
the appearance of the S2-33actin crosslink (Fig. 4). The yield 
of S2-3 crosslinking to F-actin as a function of total added 
S2-3 is significantly lower when S2-3 was added to preformed 
filaments that were first saturated with the PS2 than in its 
absence, indicating that S2-3 has to displace PS2 prior to 
binding. 
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3.4. Filament severing by gelsolin is slower in the presence of 
PS2 
We tested the severing activity of human plasma gelsolin in 
the absence and presence of PS2 using a dilution assay. We 
incubated precapped filaments with PS2 in concentrations at 
which, considering the determined Kd value for the actin-PS2 
complex, all F-actin should be complexed. We next diluted the 
sample 1Zfold to final actin and PS2 concentrations of 0.4 
and 100 PM, respectively. Fig. 5 shows the rate of depolymer- 
ization as a function of time. Interestingly, adding the peptide 
to pyrenylated F-actin results in a higher fluorescence suggest- 
ing that the environment of the fluorophore changes upon 
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Fig. 2. Actin binding activity of the gelsolin segment 2 peptide PS2. 
(a) SDS analysis of EDC crosslinking between prepolymerized actin 
and PS2. The total actin concentration is 3 PM, the concentration 
of PS2 is indicated in uM above each lane. (b) SDS analysis of pel- 
lets (P) and supernatants (S) obtained after sedimentation of a EDC 
crosslinking reaction of 12 f.tM of F-actin with PS2 at the indicated 
concentration (PM). (c) The net relative fluorescence (%) is shown 
in function of total PS2 concentration of a series of samples con- 
taining 4 uM of F-actin and varying amounts of PS2 of which 10% 
NHs-terminally carries the fluorophore pyrene. Inset: Determination 
of Kd value for PS2 binding to F-actin (see Section 2). 
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Fig. 3. Circular dichroism measurements of PS2 and PSI. Mean res- 
idue weight elipticity @+~a~ is shown as a function of wavelength. 
Curves carrying the indications ‘aq.’ and ‘TFE’ result from measur- 
ing in 10 mM Na-phosphate pH 7.5 and 60% TFE in Na-phos- 
phate, respectively. 
binding of PS2 to F-actin. Adding gelsolin to this sample does 
not result in a decrease of the fluorescence which accompanies 
severing activity (compare the difference between the upper 
two curves with the one between the lower two curves in 
Fig. 5), indicating that the severing activity is considerably 
slowed down when PS2 is bound to the filament. 
3.5. Limiting the target site of PS2 in actin 
The F-actin-PS2 and F-actin-S2-3 crosslinked complexes 
were screened for recognition by a set of site-specific anti-actin 
antibodies. We used three antibodies recognizing different epi- 
topes in actin. One specifically recognizes actin residues 3% 
375 (extreme COOH-terminus) and another residues 228-257 
in actin subdomain 4. A third commercial antibody is specific 
for a-sarcomeric actin and we determined that its epitope lies 
between residues 12 and 44 (part of subdomains 1 and 2) 
(unpublished results). When the antibody fails to recognize 
the crosslinked complex, this suggests that the crosslinked 
partner is blocking its epitope on actin. This approach is 
validated by the failure of the antibody, raised against the 
COOH-terminus of actin, to recognize the actin-bovine profi- 
lin I-crosslink, as X-ray diffraction crystallography data and 
chemical crosslinking experiments have shown that the ex- 
treme actin COOH-terminus is involved in the actin-profilin 
contact [26,27]. All three antibodies recognize the F-actin-PS2 
and F-actin-S2-3-complex on Western blot as efficiently as 
the non-crosslinked actin (Fig. 6), indicating that neither the 
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extreme actin COOH-terminus, the top of actin subdomain 4 
nor a region between actin residues 12 and 44 is located at the 
site of crosslinking. 
In this report we show that the human gelsolin S2 peptide 
PS2, ranging from residues 198 to 227, binds actin filaments 
with a Kd of ca. 125 PM, which is relatively low considering 
the small size of the fragment. For comparison, the affinity of 
the total S2-3 fragment for actin filaments has been reported 
to be between 0.2 and 3 PM [ll]. The specificity of the PS2 
interaction is additionally demonstrated by its evident compe- 
tition with the total S2Z3 segment for binding to F-actin. 
Bound to the filament, PS2 hinders S2-3 binding and in addi- 
tion decelerates filament severing by intact gelsolin. 
Earlier studies have pointed out the importance in F-actin 
binding of the first 23 residues of segment 2 in gelsolin and 
related proteins. A synthetic peptide from the NHz-terminus 
of S2 (residues 133-147 in villin, 159-171 in gelsolin) binds to 
filaments [17]. These data are not necessarily in conflict with 
the new F-actin binding site we identified here. Truncation 
analysis shows that mutants containing Sl in combination 
with these 23 residues have severing activity, for which F-actin 
binding is a prerequisite. However, the severing activity is 
severely reduced indicating that not all binding information 
is present in this mutant. We hypothesize that this NHz-ter- 
minal S2 region (150-173) and the a-helical segment we iden- 
tified in the COOH-terminus (residues 198-227) cooperate to 
form the F-actin binding site of gelsolin and that both se- 
quences are necessary to obtain full side-binding and severing 
activity. Diverse data underlie our cooperative binding model. 
First, S2 is presumed to bind to more than one subunit in the 
filament [28]. An interaction of this kind would logically de- 
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than the small site described so far. Second, both in the Sl 
[12] and the S2 (severin) structure [14], the NHz-terminal re- 
gion and the long (actin binding) helix are spatially proximal, 
supporting a possible combined action of these two regions in 
the contact with the filament. In addition, such a proposed 
combined action of an NHz-terminal and a COOH-terminal 
part in S2 would be similar to the one observed in Sl. Resi- 
dues Asp”’ and Pheso located in the Sl NHz-terminus between 
P-strands 1 and 2 participate, together with residues from the 
cc-helix (95-112), in forming a contact with actin [12]. 
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Fig. 4. Competitive binding of PS2 and gelsolin S2-3 to F-a&in. 
SDS analysis of EDC crosslinking of 3 FM F-actin preincubated 
with 30 pM PS2 to which increasing concentrations of S2-3 (indi- 
cated above each iane in pitij were added. The iane headed ‘A’ con- 
tains actin without PS2. The non-crosslinked S2-3, non-crosslinked 
Sactin, the actin-PS2 and actin-S2-3 crosslink are indicated by an 
asterisk, an arrow, an arrowhead and a dot, respectively. 
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Fig. 5. We diluted F-actin, capped at the barbed end, and preincu- 
bated with PS2 in G-buffer in the presence (a) and absence (b) of 
gelsolin (0.4, 100 and 0.05 uM final concentrations of actin, PS2 
and gelsolin). The same was done with omission of PS2 (c and d). 
The relative fluorescence is shown as a function of time, with meas- 
urements starting 30 s after dilution. 
Sun et al. [16] reported that an NHz-terminal deletion mu- 
tant of S2 containing residues 173-266, and thus also the PS2 
sequence, no longer bound to F-actin. The loss in F-actin 
binding activity they observed can be due to the fact that 
residues 196226 on their own bind with too low an affinity 
for complex formation to be detected in the assay used; how- 
ever, more likely, as put forward by these authors themselves, 
it can be due to a changed conformation of this truncated S2 
as their gel filtration analysis revealed that this mutant has a 
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Fig. 6. Western blot analysis of the EDC crosslinking of actin alone 
(lane 7), actin and S2-3 (lanes 1, 3, 5), actin and PS2 (lanes 2, 4, 6) 
and actin and human profilin I (lanes 8, 9) using anti-actin specific 
antibodies against residues 228-257 (lanes 5, 6), 354375 (lanes 3, 4, 
9) and a monoclonal antibody specific for cc-sarcomeric actin (lanes 
1, 2, 7, 8). The positions of the non-crosslinked actin, the actin 
PS2, the actin-S2-3 and the actinprofilin I crosslink are indicated 
by an arrow, an arrowhead, a dot and an asterisk, respectively. 
more elongated shape than the intact S223 and despite its 
smaller mass elutes earlier from the column. 
The SZ-F-actin binding sequence we newly identify here is 
located in the second half of segment 2 and is homologous to 
the actin binding site of segment 1 [12]. In Sl, the central part 
of this sequence forms an a-helix that contributes to a large 
extent to the actin contact. Following the generally accepted 
view - which is strongly supported by the high structural 
similarity between Sl of gelsolin and S2 of severin [14] - 
that all segments in gelsolin adopt a same overall fold, the 
sequence we studied in S2 should also contain an a-helix. Our 
CD measurements indeed prove that the S2 peptide can adopt 
an a-helical conformation, albeit a very unstable one in aqu- 
eous solution at room temperature. However, as the corre- 
sponding Sl peptide (Fig. 1) reveals a similar low helical sta- 
bility under the same conditions (Fig. 3) we may conclude 
that the PS2 sequence will be a-helical in the gelsolin protein. 
In Fig. 7, we plotted PS2 on an a-helical wheel (starting 
from Ser202) and compared it with the Sl actin binding helix. 
Most residues conserved between segments in the gelsolin 
family prove to be important in the internal packing of the 
domains in this case the packing of the o-helix onto the un- 
derlying p pleated sheet [29]. Fig. 7 shows these residues 
(shaded) for Sl and S2 of gelsolin and S2 of severin. The 
amino acids at the opposite side of the helix participate in 
actin binding, not only in Sl but, as shown here, also in S2. 
However, Sl and S2 bind to different sites on the actin fila- 
ment because recombinant Sl and S223 can bind simulta- 
RES.172.7ST 
Fig. 7. Helical wheel presentation of the actin binding helices of gelsolin segments 1 and 2 and severin segment 2 [12,13]. Residues directed to- 
wards the gelsolin Sl and severin S2 core and the homologous residues in gelsolin S2 are shaded. The side of the gelsolin segment 1 helix 
known to face actin [12] is indicated. 
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neously to actin [8]. From the crystal structure it is clear that 
Sl binds between actin subdomains 1 and 3 [12]. From a 
mechanistic point of view, S2 is proposed to bind along the 
filament. MacGough and Way [30] modelled the ol-actinin 
All2, which can functionally replace S2-3 [ll], on F-actin 
and showed that contacts are made with subdomain 2 and 
subdomain 1 of two neighboring protomers along the long- 
itudinal axis. Our immune data demonstrate that S2-3 and 
PS2 bind neither between actin residues 21l44 (the solvent 
exposed part of the epitope of the sarcomeric a-actin specific 
antibody) nor (unlike Sl) near the COOH-terminus of actin. 
The latter again stresses the different target sites of Sl and S2 
on actin. This distinction must arise from variation in the 
residues on the solvent exposed side of the actin binding helix 
in Sl and S2 as illustrated in Fig. 7. The hydrophobic char- 
acter of Sl residues Ilo and V lo6 both essential in the contact 
with actin subdomain 1, is not conserved in S2 of gelsolin and 
related proteins. L212, the only hydrophobic residue on the 
solvent exposed site of the S2 helix, is not present in the 
second domain of other gelsolin family members. However, 
the basic character of S2 residues 211, 213 and 222 is abso- 
lutely conserved throughout different S2 segments in both 
vertebrate and invertebrate species suggesting they are func- 
tionally relevant. The corresponding residues in Sl are acidic 
or uncharged. This indicates that although Sl and S2 are 
highly similar in overall structure, homologous surface regions 
of both segments (the solvent exposed residues in 955112 [12] 
and 198-227 (this study)) have evolved to generate different 
actin binding properties. Thus, divergent evolution has pro- 
duced a more powerful modulator of actin function. 
In summary, this report contributes to understanding the 
complex mode of interaction of gelsolin and related proteins 
with actin filaments. Using a peptide mimetic, we identified 
extra residues of gelsolin involved in filament side-binding. As 
these are located in S2 at an analogous position as the actin 
binding helix of Sl, the parallel between Sl and S2 that was 
already evident at the level of domain structure can be further 
extended. A positionally similar part of both segments is pre- 
sented to actin, although the surface residues have evolved to 
fit the different actin target sites of Sl and S2. 
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